Cargando…

Carcinoid Syndrome: A Review

Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gade, Ajay K, Olariu, Eva, Douthit, Nathan T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124884/
https://www.ncbi.nlm.nih.gov/pubmed/32257725
http://dx.doi.org/10.7759/cureus.7186
_version_ 1783515851724423168
author Gade, Ajay K
Olariu, Eva
Douthit, Nathan T
author_facet Gade, Ajay K
Olariu, Eva
Douthit, Nathan T
author_sort Gade, Ajay K
collection PubMed
description Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and the complications of mesenteric fibrosis, including ureteral obstruction, bowel obstruction, and bowel ischemia. These symptoms are mediated by the release of serotonin (5-HT), histamine, kallikrein, prostaglandins, and tachykinins. The diagnosis of CS requires these symptoms and corresponding elevations in lab tests. Treatment options include surgery and medical management with somatostatin analogs.
format Online
Article
Text
id pubmed-7124884
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-71248842020-04-06 Carcinoid Syndrome: A Review Gade, Ajay K Olariu, Eva Douthit, Nathan T Cureus Gastroenterology Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and the complications of mesenteric fibrosis, including ureteral obstruction, bowel obstruction, and bowel ischemia. These symptoms are mediated by the release of serotonin (5-HT), histamine, kallikrein, prostaglandins, and tachykinins. The diagnosis of CS requires these symptoms and corresponding elevations in lab tests. Treatment options include surgery and medical management with somatostatin analogs. Cureus 2020-03-05 /pmc/articles/PMC7124884/ /pubmed/32257725 http://dx.doi.org/10.7759/cureus.7186 Text en Copyright © 2020, Gade et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Gade, Ajay K
Olariu, Eva
Douthit, Nathan T
Carcinoid Syndrome: A Review
title Carcinoid Syndrome: A Review
title_full Carcinoid Syndrome: A Review
title_fullStr Carcinoid Syndrome: A Review
title_full_unstemmed Carcinoid Syndrome: A Review
title_short Carcinoid Syndrome: A Review
title_sort carcinoid syndrome: a review
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124884/
https://www.ncbi.nlm.nih.gov/pubmed/32257725
http://dx.doi.org/10.7759/cureus.7186
work_keys_str_mv AT gadeajayk carcinoidsyndromeareview
AT olariueva carcinoidsyndromeareview
AT douthitnathant carcinoidsyndromeareview